Recruiting

Observational Study

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Code:

NCT06306924

Conditions

Cancer

Metastatic Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Radiation therapy

Study Details

Brief summary:

The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.

Conditions

Cancer

Metastatic Cancer

Study ID

NCT06306924

Start date

Apr 21, 2024

Status verified date

Apr, 2026

Completion date

May, 2033

Anticipated

Primary completion date

May, 2033

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

Written informed consent was obtained to participate in the study and HIPAA

Authorization for release of personal health information. Ability to understand and willingness to sign informed consent

Diagnosed with or is suspected to have metastatic cancer.

Age ≥ 18 years at the time of consent.

Evaluated to receive radiation therapy as part of their standard-of-care treatment plan.

Exclusion Criteria:

All participants must not meet any of the following exclusion criteria prior to enrollment to participate in this study:

Any serious medical or psychiatric disorder that would interfere with the participant's ability to give informed consent.

Study Design

Enrollment

2000 participants

Anticipated

Interventions and Outcome Measures

Arms

Palliative radiation therapy

Subjects who are with metastatic cancer receive palliative radiation therapy.

Interventions

Radiation therapy

Subjects with metastatic cancer receive radiation therapy.

Primary outcome measure

  • Clinical Data [ Time Frame: Up to 1 month ]

Central Contacts and Locations

Central contacts

Kadiata Toumbou

(202) 569-3721kadiata@email.unc.edu

Victoria Xu

victoria_xu@med.unc.edu

Locations

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill

Recruiting

Chapel Hill, North Carolina, United States, 27599

Contacts

Shivani Sud, MS

919-918-5924sshivani.sud@unchealth.unc.edu

Principal Investigator:

Shivani Sud, MD

More Information

Sponsor

UNC Lineberger Comprehensive Cancer Center

Last update posted

May 6, 2026

Last verified

Apr, 2026

Keywords

  • radiation therapy

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by UNC Lineberger Comprehensive Cancer Center on 2026-05-06.